Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Cell Death & Disease|October 29, 2020
miR-182-5p and miR-378a-3p regulate ferroptosis in I/R-induced renal injuryChenguang Ding, Xiaoming Ding, Jin Zheng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 3, 2024
Scutellarin alleviates renal ischemia-reperfusion injury by inhibiting the MAPK pathway and pro-inflammatory macrophage polarizationGe Deng, Bingxuan Zheng, Meng Dou, et al.
Journal of Thoracic Disease|May 20, 2021
Prognostic nomograms and risk-stratifying systems for predicting survival in patients with resected pT2-4aN0M0 esophageal carcinomaXiao-Meng Dou, Na Zhang, Yan-Yan Fang, et al.
Frontiers in Immunology|March 14, 2022
Immune-Related Genes for Predicting Future Kidney Graft Loss: A Study Based on GEO DatabaseMeng Dou, Chenguang Ding, Bingxuan Zheng, et al.
Acta Biochimica Et Biophysica Sinica|January 18, 2020
Cordycepin protects renal ischemia/reperfusion injury through regulating inflammation, apoptosis, and oxidative stressFeng Han, Meng Dou, Yuxiang Wang, et al.
The American Journal of Pathology|July 22, 2018
Assessment of Functional Phosphatidylinositol 3-Kinase Pathway Activity in Cancer Tissue Using Forkhead Box-O Target Gene Expression in a Knowledge-Based Computational ModelHenk van Ooijen, Marten Hornsveld, Christa Dam-de Veen, et al.
Molecular Medicine Reports|August 22, 2019
Role of prostaglandin E2 receptor 4 in the modulation of apoptosis and mitophagy during ischemia/reperfusion injury in the kidneyChenguang Ding, Feng Han, Heli Xiang, et al.
Journal of Cellular Biochemistry|August 22, 2018
LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinomaChenguang Ding, Feng Han, Heli Xiang, et al.
Oncology Letters|October 31, 2022
miR-20b-5p is a novel biomarker for detecting prostate cancerTian-Yuan Zhai, Meng Dou, Yu-Bo Ma, et al.
Frontiers in Surgery|November 15, 2021
A Rare Subtype of Non-small Cell Lung Cancer: Report of 159 Resected Pathological Stage I-IIIA Pulmonary Lymphoepithelioma-Like Carcinoma CasesRong-Rong Jiang, Xiao-Li Feng, Wen-Ting Zhu, et al.
Pageof 6